Kearney M M, Soule E H, Ivins J C
Cancer. 1980 Jan 1;45(1):167-78. doi: 10.1002/1097-0142(19800101)45:1<167::aid-cncr2820450127>3.0.co;2-8.
A retrospective study of 167 patients with soft-tissue malignant fibrous histiocytoma of the trunk, extremities, and retroperitoneal region revealed twice as many deeply situated tumors as superficial tumors. Malignant fibrous histiocytoma may be subclassified into fibrous, giant-cell, myxoid, and inflammatory variants. The fibrous variant accounted for two-thirds of the lesions. The prognosis is no different among the histologic subtypes. The depth of the tumor significantly affects survival, and three important groups were identified: superficial tumors, superficial tumors that recur in deep locations, and deeply situated tumors. The group with superficial tumors that subsequently did not recur in deep locations had a significantly better 4-year survival rate than did the other two groups (65% versus 34% and 40%, respectively). Patients with distally located tumors had a better 5-year survival rate than did patients with proximally located tumors (73% versus 28%). Local recurrence was found in 51% of patients who had a "complete" excision. Patients with superficial tumors had a higher local recurrence rate (71%) than did those with deep tumors (41%). Few patients with retroperitoneal tumors were long-term survivors; the 5-year survival rate was 14%.
一项针对167例躯干、四肢及腹膜后软组织恶性纤维组织细胞瘤患者的回顾性研究显示,深部肿瘤的数量是浅表肿瘤的两倍。恶性纤维组织细胞瘤可细分为纤维型、巨细胞型、黏液型和炎症型。纤维型占病变的三分之二。组织学亚型之间的预后无差异。肿瘤深度显著影响生存率,确定了三个重要组:浅表肿瘤、在深部复发的浅表肿瘤和深部肿瘤。随后未在深部复发的浅表肿瘤组的4年生存率明显高于其他两组(分别为65%对34%和40%)。肿瘤位于远端的患者5年生存率高于近端肿瘤患者(73%对28%)。在接受“根治性”切除的患者中,51%出现局部复发。浅表肿瘤患者的局部复发率(71%)高于深部肿瘤患者(41%)。腹膜后肿瘤患者很少有长期存活者;5年生存率为14%。